US Stock MarketDetailed Quotes
OKYO OKYO Pharma
- 1.060
- -0.030-2.75%
Close Dec 20 16:00 ET
- 1.090
- +0.030+2.83%
Post 20:01 ET
35.87MMarket Cap-1.86P/E (TTM)
1.090High1.040Low30.54KVolume1.060Open1.090Pre Close32.60KTurnover0.13%Turnover RatioLossP/E (Static)33.84MShares1.95052wk High-6.09P/B25.36MFloat Cap0.80852wk Low--Dividend TTM23.92MShs Float7.000Historical High--Div YieldTTM4.59%Amplitude0.808Historical Low1.067Avg Price1Lot Size
About OKYO Pharma Company
OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
Company Profile
SymbolOKYO
Company NameOKYO Pharma
Issue Price4.00
Founded2007
CEODr. Gary S. Jacob, PhD
MarketNASDAQ
Employees3
Fiscal Year Ends03-31
Address107 Cheapside,9th Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeEC2V 6DN
Phone44-20-7495-2379
Websitehttp://www.okyopharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Gary S. Jacob, PhD
- Chief Executive Officer and Director
- 1.11M
- Keeren Shah
- Chief Financial Officer
- --
- Dr. Raj Patil
- Chief Scientific Officer
- --
- Gabriele Marco Antonio Cerrone, M.B.A.
- Chairman of the Board
- 1.31M
- Willy Jules Simon
- Senior Independent Director
- 50.00K
- John Patrick Brancaccio
- Independent Director
- 86.00K
- Bernard F. Denoyer
- Independent Director
- 51.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data